Particle.news
Download on the App Store

Nature Study Identifies SCAN as Core Parkinson’s Network, Doubling TMS Response in Small Trial

The study links symptoms to hyperconnectivity between motor planning regions and subcortical circuits, prompting larger trials of personalized neuromodulation.

Overview

  • Researchers analyzed brain-imaging datasets from 863 participants across U.S. and China cohorts, finding a Parkinson’s-specific pattern of SCAN hyperconnectivity to subcortical regions not seen in other movement disorders.
  • Standard therapies including levodopa, deep brain stimulation, transcranial magnetic stimulation, and focused ultrasound were most effective when they reduced SCAN–subcortex connectivity, with larger reductions tracking with better motor outcomes.
  • In a randomized comparison, SCAN-targeted transcranial magnetic stimulation produced a 56% response rate over two weeks versus 22% when stimulating adjacent cortical areas (18 patients per group).
  • Experts say the results reframe Parkinson’s as a brain-network disorder that integrates movement with cognition, arousal, and internal body control rather than a purely basal ganglia motor disease.
  • Causality remains unclear between dopamine neuron loss and network dysfunction, and investigators are moving to larger clinical trials and noninvasive, precision-targeted device development, including efforts by WashU-linked Turing Medical.